Conformis Inc(NASDAQ:CFMS) stock News

CFMS Latest News, Press Relases and Analysis

All

Press Releases

2 years ago - By: Conformis, Inc.

restor3d Completes Acquisition of Conformis

2 years ago - By: Conformis, Inc.

Independent Proxy Advisory Firm ISS Recommends Conformis Stockholders Vote “FOR” the Pending Merger with restor3d

2 years ago - By: Conformis, Inc.

Conformis Reports Second Quarter 2023 Financial Results

2 years ago - By: Benzinga

Why Conformis Stock Is Shooting Higher Today

3 years ago - By: Benzinga - Mentions: ONCS BMRA MLSS ARDX ...

12 Health Care Stocks Moving In Friday's Pre-Market Session

2 years ago - By: Brodsky & Smith LLC - Mentions: NETI NEX PTEN FRG

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Conformis, Inc. (Nasdaq – CFMS), Eneti Inc. (NYSE – NETI), Franchise Group, Inc. (Nasdaq – FRG), NexTier Oilfield Solutions Inc. (NYSE – NEX)

2 years ago - By: Kahn Swick & Foti, LLC

CONFORMIS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Conformis, Inc. - CFMS

2 years ago - By: Ademi LLP

Shareholder Alert: Ademi LLP investigates whether Conformis, Inc. has obtained a Fair Price in its transaction with restor3d

2 years ago - By: Halper Sadeh LLC

CFMS Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Conformis, Inc. Is Fair to Shareholders

2 years ago - By: InvestorPlace - Mentions: ONCS CTM NVVE SRGA ...

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

2 years ago - By: Conformis, Inc.

Conformis Announces Definitive Agreement to be Acquired by restor3d for a Purchase Price of $2.27 Per Share in Cash

2 years ago - By: Conformis, Inc.

Conformis Reports First Quarter 2023 Financial Results

2 years ago - By: Conformis, Inc.

Conformis, Inc. to Announce Financial Results for Its First Quarter on May 8, 2023

3 years ago - By: Conformis, Inc.

Conformis Launches Patient Awareness Campaign to Highlight the Benefits of Personalized Knee Replacement Procedures

3 years ago - By: Conformis, Inc.

Conformis, Inc. Reports Fourth Quarter and Year End 2022 Financial Results

3 years ago - By: Conformis, Inc.

Conformis, Inc. to Participate in Upcoming Investor Conferences

3 years ago - By: Seeking Alpha

Conformis settles patent dispute with Bodycad (NASDAQ:CFMS)

3 years ago - By: Conformis, Inc.

Conformis, Inc., Bodycad Laboratories, Inc. and Bodycad USA Corp. Announce Settlement of Patent Litigation

3 years ago - By: Seeking Alpha

Conformis Q4 preliminary revenue above estimates (NASDAQ:CFMS)

3 years ago - By: Conformis, Inc.

Conformis Provides Business Update and Reports Preliminary Results for Fourth Quarter and Full-Year 2022

3 years ago - By: Conformis, Inc.

Conformis Inc (CFMS) Stock News

CFMS Latest News, Press Relases and Analysis

restor3d Completes Acquisition of Conformis

Independent Proxy Advisory Firm ISS Recommends Conformis Stockholders Vote “FOR” the Pending Merger with restor3d

Conformis Reports Second Quarter 2023 Financial Results

Why Conformis Stock Is Shooting Higher Today

12 Health Care Stocks Moving In Friday's Pre-Market Session

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Conformis, Inc. (Nasdaq – CFMS), Eneti Inc. (NYSE – NETI), Franchise Group, Inc. (Nasdaq – FRG), NexTier Oilfield Solutions Inc. (NYSE – NEX)

CONFORMIS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Conformis, Inc. - CFMS

Shareholder Alert: Ademi LLP investigates whether Conformis, Inc. has obtained a Fair Price in its transaction with restor3d

CFMS Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Conformis, Inc. Is Fair to Shareholders

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

Conformis Announces Definitive Agreement to be Acquired by restor3d for a Purchase Price of $2.27 Per Share in Cash

Conformis Reports First Quarter 2023 Financial Results

Conformis, Inc. to Announce Financial Results for Its First Quarter on May 8, 2023

Conformis Launches Patient Awareness Campaign to Highlight the Benefits of Personalized Knee Replacement Procedures

Conformis, Inc. Reports Fourth Quarter and Year End 2022 Financial Results

Conformis, Inc. to Participate in Upcoming Investor Conferences

Conformis settles patent dispute with Bodycad (NASDAQ:CFMS)

Conformis, Inc., Bodycad Laboratories, Inc. and Bodycad USA Corp. Announce Settlement of Patent Litigation

Conformis Q4 preliminary revenue above estimates (NASDAQ:CFMS)

Conformis Provides Business Update and Reports Preliminary Results for Fourth Quarter and Full-Year 2022

Conformis, Inc. to Announce Financial Results for Its Fourth Quarter and Full-Year 2022